Current Pharmaceutical Design
Title: Editorial [Drugs Promoting Wakefulness and Performance Executive Editor: J.G. Ramaekers]
Volume: 12 Issue: 20
Author(s): J. G. Ramaekers
Affiliation:
Export Options
About this article
Cite this article as:
Ramaekers G. J., Editorial [Drugs Promoting Wakefulness and Performance Executive Editor: J.G. Ramaekers], Current Pharmaceutical Design 2006; 12 (20) . https://dx.doi.org/10.2174/138161206777698846
DOI https://dx.doi.org/10.2174/138161206777698846 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
8
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Approaches to a Multitargeting Drug Development: First Profiled 3- Ethoxycarbonyl-1-aza-9-oxafluorenes Representing a Perspective Compound Class Targeting Alzheimer Disease Relevant Kinases CDK1, CDK5 and GSK-3β
Medicinal Chemistry Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review
Current Medicinal Chemistry “Stress” is 80 Years Old: From Hans Selye Original Paper in 1936 to Recent Advances in GI Ulceration
Current Pharmaceutical Design Effects of Mindfulness on Diabetes Mellitus: Rationale and Overview
Current Diabetes Reviews Tryptamine Induces Axonopathy and Mitochondriopathy Mimicking Neurodegenerative Diseases via Tryptophanyl-tRNA Deficiency
Current Alzheimer Research Atmospheric Prebiotic Chemistry and Organic Hazes
Current Organic Chemistry The Paradox of Caffeine-Zolpidem Interaction: A Network Analysis
Current Drug Targets Apoptosis Induction by Thalidomide: Critical for Limb Teratogenicity but Therapeutic Potential in Idiopathic Pulmonary Fibrosis?
Current Molecular Pharmacology Repetitive Ritalin Treatment Modulates the Diurnal Activity Pattern of Young SD Male Rats
Central Nervous System Agents in Medicinal Chemistry Novel Drugs Affecting Tau Behavior in the Treatment of Alzheimers Disease and Tauopathies
Current Alzheimer Research Sex Impact on Biomarkers, Pharmacokinetics and Pharmacodynamics
Current Medicinal Chemistry Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets Quantitative Estimation of Software Quality in Hospital Information System
Neuroscience and Biomedical Engineering (Discontinued) Therapeutic Implications of Superoxide Dismutase And Its Importance in Kinase Drug Discovery
Current Topics in Medicinal Chemistry Oral Triphenylmethane Food Dye Analog, Brilliant Blue G, Prevents Neuronal Loss in APPSwDI/NOS2-/- Mouse Model
Current Alzheimer Research The Role of Intravenous Dihydropyridine Calcium Channel Blockers in the Perioperative Management of Patients Undergoing Coronary Artery Bypass Surgery
Current Vascular Pharmacology Polymer-Drug Nanoconjugate – An Innovative Nanomedicine: Challenges and Recent Advancements in Rational Formulation Design for Effective Delivery of Poorly Soluble Drugs
Pharmaceutical Nanotechnology Targeting Interleukin-1β for Pain
CNS & Neurological Disorders - Drug Targets α<sub>2</sub> Adrenoceptor: a Target for Neuropathic Pain Treatment
Mini-Reviews in Medicinal Chemistry Desmoteplase for Acute Ischemic Stroke: A Systematic Review and Metaanalysis of Randomized Controlled Trials
CNS & Neurological Disorders - Drug Targets